Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer

References

• Rajendran JG, Schwartz DL, O’Sullivan J, et al. Tumor Hypoxia Imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res. 2006;12:5435–5441.
   PubMed Web of Science ®Google Scholar
• Dirix P, Vandecaveye V, De Keyzer F, et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009;50:1020–1027.
   PubMed Web of Science ®Google Scholar
• Zips D, Zöphel K, Abolmaali N, et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol. 2012;105:21–28.
   PubMed Web of Science ®Google Scholar
• Chaput A, Calais J, Robin P, et al. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma. Head Neck. 2017;39:1155--1165.
   Google Scholar
• Linge A, Lohaus F, Löck S, et al. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol. 2016;121:364–373.
   PubMed Web of Science ®Google Scholar
• Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47:551–560.
   PubMed Web of Science ®Google Scholar
• Baumann M, Krause M, Overgaard J, et al. Radiation oncology in the era of precision medicine. Nat Rev Cancer. 2016;16:234–249.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Paulsen F, et al. Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys. 2007;68:291–300.
   PubMed Web of Science ®Google Scholar
• Heukelom J, Hamming O, Bartelink H, et al. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. BMC Cancer. 2013;13:84.
   PubMed Web of Science ®Google Scholar
• Duprez F, De Neve W, De Gersem W, et al. Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;80:1045–1055.
   PubMed Web of Science ®Google Scholar
• Madani I, Duthoy W, Derie C, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:126–135.
   PubMed Web of Science ®Google Scholar
• Rasmussen JH, Håkansson K, Vogelius IR, et al. Phase I trial of 18F-fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer. Radiother Oncol. 2016;120:76–80.
   PubMed Web of Science ®Google Scholar
• Welz S, Mönnich D, Pfannenberg C, et al. Prognostic value of dynamic hypoxia PET in head and neck cancer: results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. Radiother Oncol. Forthcoming. [cited 2017 Apr 20]. DOI:10.1016/j.radonc.2017.04.004
   Web of Science ®Google Scholar
• Rajendran JG, Mankoff DA, O’Sullivan F, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;10:2245–2252.
   PubMed Web of Science ®Google Scholar
• Mortensen LS, Johansen J, Kallehauge J, et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. Radiother Oncol. 2012;105:14–20.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Scheiderbauer J, et al. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer. 2005;5:152–160.
   PubMed Web of Science ®Google Scholar
• Bittner M-I, Wiedenmann N, Bucher S, et al. Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. Radiother Oncol. 2013;108:511–516.
   PubMed Web of Science ®Google Scholar
• Zegers CML, Elmpt WV, Reymen B, et al. In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging. Clin Cancer Res. 2014;20:6389–6397.
   PubMed Web of Science ®Google Scholar
• Bollineni VR, Kerner GSMA, Pruim J, et al. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III–IV non-small cell lung cancer patients. J Nucl Med. 2013;54:1175–1180.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann S-M, Paulsen F, et al. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol. 2005;50:2209–2224.
   PubMed Web of Science ®Google Scholar
• Leibfarth S, Mönnich D, Welz S, et al. A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning. Acta Oncol. 2013;52:1353–1359.
   PubMed Web of Science ®Google Scholar
• Schaefer A, Kremp S, Hellwig D, et al. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging. 2008;35:1989–1999.
   PubMed Web of Science ®Google Scholar
• Even AJG, van der Stoep J, Zegers CML, et al. PET-based dose painting in non-small cell lung cancer: comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. Radiother Oncol. 2015;116:281–286.
   PubMed Web of Science ®Google Scholar
• Mönnich D, Welz S, Thorwarth D, et al. Robustness of quantitative hypoxia PET image analysis for predicting local tumor control. Acta Oncol. 2015;54:1364–1369.
   PubMed Web of Science ®Google Scholar
• Rasmussen JH, Vogelius IR, Aznar MC, et al. Spatio-temporal stability of pre-treatment 18F-fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting. Acta Oncol. 2015;54:1416–1422.
   PubMed Web of Science ®Google Scholar